| ¿µ¹® | rheumatic heart disease | ÇÑ±Û | ·ù¸¶Æ¼½º½ÉÀ庴 |
|---|---|---|---|
| ¼³¸í | »ç½½¾Ë±Õ°¨¿° ÈÄ »ý±â´Â ½ÉÀåÆÇ¸·º´ÀÌ´Ù. ¿øÀÎÀº A±º -¿ëÇ÷»ç½½¾Ë¿¡ ÀÇÇÑ Àεο°ÈÄ ÀÏÁ¾ÀÇ ¸é¿ª¹ÝÀÀÀ¸·Î ¹ßº´ÇÑ´Ù. Áø´ÜÀº Á¸ÀÇ ±âÁØ¿¡ ÀÇÇÑ´Ù. (1) ÁÖ¿ä±âÁØÀº °üÀý¿° ½ÉÀå¿°(½ÉÀåºñ´ë, ½ÉÀåÀâÀ½, ½ÉÀå±â´É»ó½Ç µî) ¹«µµÁõ: ¹«´çÀÌ ÃãÀ» Ãß´Â °Í °°Àº ÇൿÀÇ ¹ßÀÛÁõ¼¼. ¿¬º¯È«¹Ý: »¡°£ Å׵θ®¸¦ °¡Áø ÇǺκ´º¯Àº ÇÇÇϰáÀý(subcutaneous nodule): ÇǺΠ¹Ø¿¡ »ý±ä °áÀý, (2)Âü°í ±âÁØÀº ¿, °üÀýÅë, EKG»ó PR¿¬Àå: ½ÉÀüµµ ¼Ò°ß ±Þ¼º±â ¹ÝÀÀ¹°Áú(¿¹: ESR, CRP)ÀÇ »ó½Â, ·ù¸¶Æ¼½º¿ Ä¡·á´Â Æä´Ï½Ç¸°À¸·Î Ä¡·áÇÏ°í ½ÉÀåÀÇ ÈÄÀ¯Áõ ¶ÇÇÑ Æä´Ï½Ç¸°À¸·Î ¿¹¹æÇÑ´Ù. |
||
| ¿µ¹® | congenital heart disease | ÇÑ±Û | ¼±Ãµ½ÉÀ庴 |
|---|---|---|---|
| ¼³¸í | ¼±ÃµÀûÀ¸·Î ½ÉÀåÀÇ ±¸Á¶¿¡ ÀÌ»óÀÌ ÀÖ´Â º´. |
||
| ¿µ¹® | heart failure | ÇÑ±Û | ½ÉÀå±â´É»ó½Ç |
|---|---|---|---|
| ¼³¸í | ¸öÀÇ Á¶Á÷À̳ª ±â°ü¿¡¼ ´ë»ç¿¡ ÇÊ¿äÇÑ ¸¸Å ÃæºÐÇÑ ¾çÀÇ Ç÷¾×À» °ø±ÞÇÒ ¼ö ¾øÀ» Á¤µµ·Î ½ÉÀå±â´ÉÀÌ ÀúÇϵǾî ÀÖ´Â »óÅÂÀÌ´Ù. ½ÉÀå±â´É»ó½ÇÀº ½É±ÙÀÌ ¼öÃàÇÒ ´É·ÂÀÌ ÀúÇϵǾúÀ» ¶§³ª ½ÉÀå¿¡ ½É¹ÚÃâÀ» Çϱâ À§ÇÑ ¾Ð·ÂÀÌ Á¤»óº¸´Ù Áõ°¡µÇ¾î Á¤»óÀÇ ½ÉÀåÀÇ ¼öÃàÀ¸·Î´Â ÃæºÐÇÑ ¾çÀÇ Ç÷¾×À» °ø±ÞÇÒ ¼ö ¾ø´Â °æ¿ì, ±×¸®°í ½ÉÀå±ÙÀ°, ½ÉÀå¿¡ °É¸®´Â ¾Ð·ÂÀº Á¤»óÀ̳ª ½ÉÀå¹Úµ¿ÀÇ ÀÌ»ó¿¡ ÀÇÇØ¼ Á¤»óÀûÀÎ ¼öÃàÀÌ ºÒ°¡´ÉÇÒ °æ¿ì¿¡ »ý±ä´Ù. |
||
| ¿µ¹® | pacemaker(of heart) | ÇÑ±Û | ½ÉÀå¹Úµ¿±â |
|---|---|---|---|
| ¼³¸í | ½ÉÀåÀÇ Àü±âÀû ÀÚ±ØÀÌ º´ÀûÀÎ »óÅ·Π¹ß»ýÇÏÁö ¾Ê°Å³ª, ȤÀº ½É½Ç·Î Àß ÀüÇØÁöÁö ¾ÊÀ» ¶§ »ç¿ëÇÑ´Ù. ÀϽÃÀû ½ÉÀå¹Úµ¿±â¿Í ¿µ±¸Àû ½ÉÀå¹Úµ¿±â°¡ ÀÖÀ¸¸ç, °¢±â ¾²ÀÌ´Â ¿ëµµ´Â º´¿¡ µû¶ó ´Ù¸£´Ù. ¿äÁò¿¡ ³ª¿À´Â ½ÉÀå ¹Úµ¿±â´Â °ÇÀüÁöÀÇ ¼ö¸íµµ ¹Ý¿µ±¸ÀûÀ̸ç, ¹Û¿¡¼ Á¶Á¤ÇÒ ¼ö ÀÖ°í, ¿îµ¿À̳ª ½ºÆ®·¹½º »óȲ¿¡ ´ëÇÑ ½ÉÀåÀÇ ºü¸¥ ¿îµ¿¿¡µµ Àß ÀûÀÀÇÒ ¼ö ÀÖµµ·Ï ¸¸µé¾îÁ® ÀÖ´Ù. |
||
| HHT | head halter traction; hereditary hemorrhagic telangiectasia; heterotopic heart transplantation; homo... |
|---|---|
| HLT | heart-lung transplantation; human lipotropin; human lymphocyte transformation |
| AJKD | American Journal of Kidney Diseases |
| JOC | Journal of Oncologic Clinical(?) |
| AEM | Academic Emergency Medicine [journal]; analytical electron microscopy; ambulatory electrocardiograph... |
| ISHLT | International Society for Heart and Lung Transplantation |
|---|---|
| OHT | Orthotopic heart transplantation |
| AlloBMT | Allogeneic Bone Marrow Transplantation |
| ABMT | Allogeneic bone marrow transplantation |
| Allo-PBSCT | Allogeneic peripheral blood stem cell transplantation |
| neoplasm transplantation | Experimental transplantation of neoplasms in laboratory animals for research purposes. (12 Dec 1998) |
|---|---|
| nuclear transplantation | <procedure> Experimental approach in study of nucleo cytoplasmic interactions, in which a nucleus is transferred from one cell to the cytoplasm (which may be anucleate) of a second. (18 Nov 1997) |
| islets of langerhans transplantation | The transference of pancreatic islets within an individual, between individuals of the same species, or between individuals of different species. (12 Dec 1998) |
| organ transplantation | Transference of an organ between individuals of the same species or between individuals of different species. (12 Dec 1998) |
| tendon transplantation | Insertion of a slip from the tendon of a sound muscle into the tendon of a paralysed muscle, replacement of a length of tendon by a free graft. (05 Mar 2000) |
| tissue transplantation | Transference of tissue within an individual, between individuals of the same species, or between individuals of different species. (12 Dec 1998) |
| tooth transplantation | The transfer of a tooth from one alveolus to another. (05 Mar 2000) |
| transplantation | <surgery> The grafting of tissues taken from the patients own body or from another. Origin: L. Plantare = to plant (18 Nov 1997) |
| transplantation antigen | <immunology> Any antigen that is antigenically active in graft rejection. In practice the major histocompatibility complex and the H Y antigens and to a lesser extent minor histocompatibility antigens. (18 Nov 1997) |
| transplantation, autologous | Transplantation from another site in or on the body of the individual receiving it. (12 Dec 1998) |
| transplantation chimera | An organism that, as a result of transplantation of donor genetic material, consists of two or more cell lines descended from at least two zygotes. This state results in the induction of donor-specific transplantation tolerance. (12 Dec 1998) |
| transplantation conditioning | Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation. (12 Dec 1998) |
| transplantation genetics | Genetics as applied to the transplanting of tissues from one animal to another. (05 Mar 2000) |
| transplantation, heterologous | Transplantation between animals of different species. (12 Dec 1998) |
| transplantation, heterotopic | Transplantation of tissue typical of one area to a different recipient site. The tissue may be autologous, heterologous, or homologous. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|